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Abstract 
 
Polyphenols are phytochemicals present in plants that contribute to 
their antioxidant and different pharmacological activities. Flavonoids 
comprise of one class of polyphenols which play a beneficial role in 
preventing free radical damage and owe its antioxidant property. 
Lipid peroxidation and lipid-derived oxidized products have been 
implicated in the pathogenesis of a variety of human diseases. To 
clarify the role of oxidative stress in prevention of atherosclerosis 
and hypercholesterolemia, the antioxidant status of plant extracts of 
Oroxylum indicum, Vitis vinifera and Policosanol isolated from, 
Saccharum officinarum were selected for the study. 
The extracts were evaluated by in vitro methods by monitoring the 
production of malondialdehyde as Thiobarbituric acid Reacting 
Substances (TBARs). The antihypperlipidemic activity was 
examined in cholesterol induced hyperlipidemic model using Albino 
Wistar rats.  
The result of the study exhibited significant reduction in total 
cholesterol, triglycerides, LDL-C, VLDL-C levels and remarkable 
increase in the level of HDL-C when compared to standard 
lovastatin drug. The artherogenic index and LDL-C: HDL-C risk 
ratio was also reduced to significant extent in the group treated with 
extracts. The levels of SGOT and SGPT were estimated and found to 
be significantly less than that of hyperlipidemic control group. 
The highest antihyperlipidemic activity was exhibited by total 
extract of the bark of Oroxylum indicum followed by extracts of 
fruits of Vitis vinifera and Policosanol isolated from sugarcane wax.  
 
Keywords:- Polyphenols, Antihyperlipidemic, Antioxidant, 
Oroxylum indicum, Vitis vinifera, Policosanol  
 
Introduction 
Polyphenols are phytochemicals present in plants 
that contribute to their antioxidant and different 
pharmacological activities.  Flavonoids belong to 
one class of the polyphenol family. Beneficial 
effects of polyphenols on human health are partly 
explained by their antioxidant activity. Because 
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of the antioxidative property, it is suggested that 
polyphenols may delay or prevent the onset of 
diseases such as cancer, diabetes induced by free 
radicals [1]. They also inhibit low density 
lipoprotein (LDL) oxidation and platelet 
aggregation and are reported to have negative 
correlation with incidences of coronary heart 
disease [2]. Several medicinal plants contribute 
their activities due to the presence of flavonoids 
and polyphenols.  
The present work is focused on antioxidant and 
antihyperlipidemic activity of plants of dried fruit 
of Vitis vinifera commonly known as black 
grapes, dried bark of Oroxylum indicum and 
policosanol isolated from sugarcane wax  
 
Methods 
Collection of plant material and Extraction: 
The medicinal plants selected for the study 
included Vitis vinifera [3], Oroxylum indicum and 
Policosanol isolated from sugarcane waste. The 
bark of Oroxylum indicum was procured from 
local market at Pyaydhuni, Mumbai and was 
authenticated by at Nicholas Piramal India Ltd, 
Goregaon, Mumbai, while the other two plants 
Vitis vinifera, Saccharum officinarum which are 
commonly available were authenticated at the 
laboratory of Pharmacognosy & Phytochemistry, 
Prin. K. M Kundnani College of Pharmacy, 
Mumbai and used for the study.  The voucher 
specimens have been maintained at the 
department. The dried materials of the bark of 
Oroxylum indicum fruits of Vitis vinifera, and 
waste of Saccharum officinarum were powdered 
and passed through 40 mesh to facilitate proper 
extraction and then subjected to soxhlet 
extraction using methanol as a solvent.  The 
methanolic extracts were concentrated under 
vacuum at temperature of 50 degrees. The viscous 
crude extracts obtained were further reconstituted 
in water as a suspension in tween 80 to obtain 
aqueous suspensions that were used for the final 
study. 
Quercetin, [6] a plant based polyphenol was 
isolated from the methanolic extract of Vitis 
vinifera by preparative HPLC. Policosanol [5, 6] 
was isolated from sugarcane wax by standard 
procedure. Total standardized extract of 
Oroxylum indicum in terms of ellagic acid 
equivalent [4] was used for the study using 
methanol as a solvent. All compounds isolated 
were identified and quantified by means of HPLC 
using standards and confirmed by IR. The 
quantified standardized extract were used for the 
study to determine their antioxidant activity and 
to study their role in prevention of hyperlipidemia 
and its effect on cardiovascular diseases   
  
Reagents 
The reagents used for antioxidants activity were 
thiobarbituric acid (TBA) purchased from Merck, 
Mumbai. Standard Quercetin purchased from 
Sigma Aldrich USA. The reagents required for 
anti hyperlipidemic studies were cholesterol 
obtained from Qualigens Fine Chemicals, crude 
edible coconut oil purchased from local market; 
standard drug Lovastatin was supplied as a gift 
sample  by production department of Cipla 
pharmaceuticals, Mumbai. 1, 1 Diphenyl, 2picryl 
hydrzyl (DPPH) purchased from Sigma Aldrich 
USA. The kits for estimation of biological 
parameter like SGOT, SGPT, Triglycerides and 
cholesterol were obtained from span Bio 
Diagnostics, Mumbai. All the other chemicals 
used during the study were of laboratory grade. 
 
HPLC Chemoprofiling  
The extract of Vitis vinifera was standardized by 
HPLC using gradient phase system using C18 
column and PDA detector and acetonitrile: water 
and acetic acid 0.2% as a mobile phase and 
policosanol was standardized by GC using 
dichloromethane and nitrogen as a gas. The 
extract of Vitis vinifera was quantified in terms of 
its quercetin content, Policosanol was quantified 
in terms of octacosanol content while Oroxylum 
indicum extract was standardized in terms of 
ellagic acid equivalent.  
 
Animals  
 For antioxidant activity, Swiss Albino mice (25-
30 G) of either sex were obtained from Haffkine 
Biopharmaceutical Corporation Ltd., Mumbai. 
For antihyperlipidemic study Albino Wistar rats 
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(120-150 G) of either sex male or female were 
obtained from Glenmark Pharmaceuticals Ltd, 
Mumbai. All the animals were housed under 
good hygienic conditions in the departmental 
animal house of Prin. K. M. Kundnani College of 
Pharmacy. Animals were maintained under 
standard environmental conditions (22-28 degrees 
centigrade, 60-70% relative humidity, 12 hr L: D 
cycle) and fed with standard diet and water ad 
libitum. Animals were allowed to acclimatize to 
experimental conditions by housing them for 8-
10 days period prior to experimental study. 
                                                                        
Evaluation of protocol 
    The experimental protocol was approved by 
the Institutional Animal Ethics Committee 
(Protocol No-091012) and the experimental work 
was carried out as per Committee for the Purpose 
of Control and Supervision on Experiments on 
Animals (CPCSEA) guidelines. The antioxidant 
activity of plant was evaluated by different 
methods like hydroxyl, superoxide, DPPH 
scavenging activities. 
Evaluation of antioxidant activity by lipid 
peroxidation method [7, 8] 
The antioxidant activity of plant extracts was 
evaluated by calculating inhibition of lipid 
peroxidation which was performed using liver 
homogenate of mice. Mice liver homogenate 
(10%) was prepared by homogenizing the fresh 
liver in 0.15 M KCl solution. This fresh liver 
homogenate was mixed with 0.15 M KCL & tris 
hydrochloride buffer. The various extracts of 
Vitis vinifera, Oroxylum indicum and Policosanol 
at different concentrations were then added. 
Quercetin at various concentrations was used as 
standard. In vitro lipid peroxidation was initiated 
by addition of 100 µM ferrous sulphate and 100 
µM Ascorbic acid. After incubation for 1 hour at 
37 degrees, the reaction was terminated by 
addition of thiobarbituric acid and then boiled at 
95 degrees for 15 minutes for development of 
colored complex. On cooling test tubes were 
centrifuged at 4000 rpm for 10 minutes. 
Absorbance of supernatant was determined 
colorimetrically at 532 nm and percent inhibition 
of TBARs formation was calculated with respect 
to control in which no test sample was added. 
The IC50 values were calculated for all test 
material by subjecting the results to linear 
regression.  
 
Evaluation of antioxidant activity by DPPH 
method [9] 
The antioxidant activity of plant extracts was 
evaluated by using 1, 1 Diphenyl, 2picryl hydrzyl 
(DPPH) as a free radical. The absorbance was 
monitored at 516nm. Quercetin was used as a 
standard.  
 
Evaluation of antioxidant activity by 
deoxyribose method and NBT method  
The hydroxyl radical scavenging activity of plant 
extracts was evaluated by using deoxyribose 
method. The absorbance was monitored at 
532nm. Superoxide anions were generated with 
riboflavin-light-NBT system and the scavenging 
potential was assessed by measuring the 
reduction of farmazone formation as measured in 
terms of reduction in absorbance at 560 nm. 
Quercetin was used as a standard. 
 
Evaluation of antihyperlipidemic activity: 
The experimental protocol was approved by the 
Institutional Animal Ethics Committee and the 
experimental work was carried out as per 
CPCSEA guidelines. The doses were fixed after 
random trials conducted on the animals. The 
procedure was followed as per the method of 
Dhuley et al [10]. Albino Wistar rats (120-150 G) 
were randomly divided into five different groups 
each containing 6 to 8 animals as follows: 
Group 1- Control group: Vehicle control 
Group 2-Hyperlipidemic group: Cholesterol in 
coconut oil (25 
mg/kg/ day) 
was 
administered 
to   each   rats 
of this group.  
Group 3-Standard group:      Lovastatin (10 
mg/kg/day) 
was given 
along with   
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cholesterol in 
coconut oil. 
Group 4-Test group:            Rats of this group 
received 
Policosanol 
aqueous 
extract (200 
mg/kg/day) 
along with 
cholesterol in 
coconut oil. 
Group 5-Test group:      Rats of this group 
received Vitis 
vinifera 
aqueous 
extract (200mg 
/kg/day) along 
with 
cholesterol in 
coconut oil. 
Gr    Group 6-Test group:            Rats of this group 
received Oroxylum 
indicum aqueous 
extract 
(200mg/kg/day) 
along with 
cholesterol in 
coconut oil. 
 
 The cholesterol in coconut oil was administered 
to each animal except the vehicle control group 
daily at 10.00 am. The solution of extract and 
standard drug were prepared freshly every day 
and administered to the test animals in their 
respective groups at 3.00 pm. This process was 
followed for 28 days and the amount of food 
intake was monitored daily. At the end of the 
experimental studies animals were fasted for 12 
hrs and the blood was collected by cardiac 
puncture under light ether anesthesia. Animals 
were then sacrificed and the livers were isolated 
and preserved in 10% formalin solution [11]. The 
biochemical parameters that were evaluated using 
Span Diagnostic Kits were Total Cholesterol 
(TC), Low Density Lipoprotein Cholesterol 
(LDL-C), Very Low Density Lipoprotein 
Cholesterol (VLDL-C), High Density Lipoprotein 
Cholesterol (HDL) and Triglycerides (TAG) from 
the serum. The artherogenic Index and LDL-C: 
HDL-C ratios were calculated to determine the 
cardiac risk factors [12]. The activities of marker 
enzymes like Serum Glutamate Oxaloacetate 
Transaminase (SGOT) and Serum Glutamate 
Pyruvate Transaminase (SGPT) were also 
estimated.  
 
Statistical Analysis 
All the results were subjected to statistical 
analysis using one way Annova followed by 
Dunnet’s multiple comparison tests against the 
hyperlipidemic group. The p values < 0.01 were 
considered statistically significant. All the values 
were expressed as mean+ S.E.M and compared 
with control group for estimation of 
antihyperlipidemic activity of test extracts. 
 
Results & Discussion 
Antioxidant Activity 
Polyphenols and flavonoids comprise a 
ubiquitous class of alternative antioxidants and 
protect against the invasion of these free radicals. 
Literature survey sites the prevention role of 
these antioxidants in prevention of atherosclerosis 
and congestive heart diseases (1, 2). The findings 
in the present investigation have confirmed the 
contributory role of antioxidants in the lowering 
of cholesterol levels in experimental animals. 
The antioxidant activity evaluation using in vitro 
methods revealed highest antioxidant activity for 
Vitis vinifera extract. The observed activity may 
be mainly due to the presence of polyphenols and 
flavonoids abundant in the extract like resveratrol 
and phytostilbenes, anthocyanins like 
delphinidin, cyanidin, flavonols like Quercetin, 
rutin and several biflavonids, carrotenoids and 
several Vitamin B derivatives as cited in the 
literature (13).  The extract of Oroxylum indicum 
contains ellagic acid, beta sitosterol, coumaric 
acid and flavones like oroxylin which could be 
one of the mechanism by which it owes 
significant antioxidant activity by virtue of its 
polyphenol content (14). Policosanol is a mixture 
of long-chain aliphatic alcohols isolated from 
sugar cane (Saccharum officinarum) wax, whose 
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main component is octacosanol which contribute 
to less antioxidant activity as compared to 
polyphenolic components present in other 
extracts. (Table A) 
 
Table -A. Antioxidant activity of extracts by in vitro 
lipid peroxidation & DPPH. 
 
Extracts 
(Aqueous) 
DPPH 
IC50 
(µg/ml) 
Supero-
xide 
radical 
scaven-
ging  
IC50 
(µg/ml) 
Hydroxyl 
radical 
scaven-
ging 
IC50 
(µg/ml) 
Lipid 
peroxi-
dation 
IC50 
(µg/ml) 
Vitis vinifera 
extract 
68.25 59.57 46.98 41.83 
Policosanol 
Extract 
91.76 112.74 97.06 101.57 
Oroxylum 
indicum 
extract 
76.30 65.48 52.23 53.29 
Quercetin 22.63 42.56 33.32 29.61 
 
HPLC Chemoprofiling. 
The HPLC chromatogram (Figure- 1) shows 
Quercetin isolated from Vitis vinifera extract and 
comparison of the same with standard Quercetin 
purchased from Sigma Aldrich. The HPLC 
chromatogram (Figure 2) depicts policosanol 
isolated from sugarcane wax.  Figure 3 depicts a 
spectrophotometric method for determination of 
polyphenols in terms of ellagic acid with the 
standard curve of ellagic acid a constituent 
present in Oroxylum indicum. These studies 
depict the use of standardization of the extract in 
terms of active contents. 
 
Antihyperlipidemic activity.  
Since hyperlipidemia, inflammation and obesity 
are closely related to atherosclerosis, therefore 
management of these factors together would be 
beneficial for overall treatment approach for 
atherosclerosis. Although, Indian system of 
medicine, especially Ayurveda has several 
medicinal plants with proven beneficial claims 
 
Figure 1 Depicting chromatogram of Quercetin and querctin standard isolated from Vitis vinifera. 
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towards these pathological conditions, but most 
of them lack enough experimental data. In this 
paper, antioxidant, antihyperlipidemic, properties 
of plant extracts have been studied on several 
experimental models based on chemical tests, in 
vitro models, and in vivo experiments with 
normal animals. 
Deranged serum lipid profile with high levels of 
triglycerides, total cholesterol, LDL cholesterol, 
and lower high density lipoproteins (HDL) are 
some of the basic causes, which should be 
targeted to prevent atherosclerotic disease. If not 
managed in the early stage, it leads to the 
formation of foam cells, resulting to the release of 
inflammatory cytokines and endothelial cells 
dysfunction. From pathological point, 
atherosclerosis may be characterized by the 
progressive accumulation of lipid and fibrous 
depositions in the vessel wall, loaded with 
monocyte-derived macrophages; smooth muscle 
derived foam cells and activated T cells. 
 
Figure 2 Depicting chromatogram of policosanol isolated from sugarcane wax 
A major culprit in the development of 
atherosclerosis is oxidized LDL (13) which 
contributes to increase in the level of cholesterol 
and triglycerides in the blood. The further step 
leads to development of atherosclerotic plaques 
leading to myocardial infarction. Several 
mechanisms have been a contributing factor in 
these cardiac ailments one of them being attack 
of free radicals in the body leading to 
atherosclerosis and congestive heart diseases 
(CHD).  Free radicals may contribute to 
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atherogenesis by oxidizing low density 
lipoproteins (LDL) which then damage arterial 
walls [13]. The oxidation of LDL cholesterol is 
suspected to occur at the initial stages of 
atherosclerosis, and antioxidants have been 
shown to inhibit this oxidative reaction and 
prevent the body from these invading free 
radicals [14]. Common primary causes of 
hypercholesterolemia (specifically, high LDL 
cholesterol) include diet, obesity hypothyroidism 
(that is, low thyroid hormone levels), pregnancy, 
and kidney failure and attack of free radicals in 
the body. Common secondary causes of 
hypertriglyceridemia include diabetes, excess 
alcohol intake, obesity, and certain prescription 
medications (such as glucocorticoids and 
estrogen). Hyperlipidemia, along with diabetes, 
hypertension (high blood pressure), positive 
family history, and smoking are all major risk 
factors for coronary heart disease (15, 16). 
Polyphenols and flavonoids act as alternative 
antioxidants and protect from these free radical 
damage thereby preventing atherosclerosis and 
cardiovascular diseases.  
As free radicals generation & induction of 
inflammation (15, 17, 18) are the primary causes 
of atherogenesis, therefore antioxidant & anti 
hyperlipidemic potential of plant extracts were 
investigated on various experimental models. The 
principal radicals responsible for hyperlipidemia 
and progression of atherosclerosis were hydroxyl 
and superoxide radicals. Reduction in levels of 
these radicals in the body could cause decrease in 
the incidences of atherosclerosis and congestive 
heart diseases. An in vitro study showed that 
plant extracts significantly scavenged the 
superoxides and hydroxyl (OH) radicals in a 
standardized chemical system as described (Table 
A). The present study reveals that extracts of Vitis 
vinifera and Oroxylum indicum shows inhibition 
of hydroxyl, superoxide radicals and 
thiobarbituric acid reacting substances (TBARs) 
followed by policoosanol. 
Table B: Effect of plant extracts on the serum lipid profile 
Values are Mean± S.E. of 6 animals. 
P-values: * < 0.01   
 
Groups TC 
(mg/dl) 
TAG 
(mg/dl) 
HDL-C 
(mg/dl) 
LDL-C 
(mg/dl) 
VLDL-C 
(mg/dl) 
Control group 61.00±1.14* 48.80±4.12* 39.60±0.58* 12.60±1.23* 8.640±1.42* 
Hyperlipidemic group 120.00±1.41 190.6±3.61 16.36±0.53 65.52±1.48 38.12±0.72 
Standard group lovastatin 
(10 mg/kg/day) 
73.60±2.58* 90.00±6.23* 24.46±0.71* 31.13±2.34* 18.00±1.24* 
Policosanol 67.60±2.48* 159.8±8.87* 29.91±4.43* 5.72±0.99* 31.96±1.77* 
Vitis vinifera 64±2.82* 123.2±9.74* 32±1.83* 7.36±2.04* 24.64±1.94* 
Oroxylum indicum 47±1* 51.60±2.05* 34.49±0.55* 2.91±1.12* 10.32±0.44* 
In the present study the extract of Oroxylum 
indicum exhibited highest activity followed by 
Vitis vinifera followed by policosonal in 
cholesterol induced hyperlipidemic model in 
Albino Wistar rats, better than that observed with 
standard drug Lovastatin. The levels of TC, LDL-
C, VLDL-C and TAG were found to be 
considerably less than standard Lovastatin drug 
(Table B). The atherogenic index and LDL-C: 
HDL-C ratio was found to be less than Lovastatin 
group (Table C) which could be one contributing 
factor in the development of atherosclerosis & 
congestive heart diseases (CHD). 
In hyperlipidemic model, the purpose of inclusion 
of cholesterol and coconut oil is attributed to the 
very well established findings that addition of 
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dietary cholesterol along with saturated fats 
results in accumulation of intracellular 
cholesterol and its ester in the body tissues as 
coconut oil contains approximately 92% of 
saturated fatty acids (FA): of short chain 15%, 
medium chain 64.2% and long chain 12.2% [19]. 
Antihyperlipidemic agents which are active in 
cholesterol induced hyperlipidemic model 
function by one or more mechanisms.  
The current therapy for treatment of 
hyperlipidemia mainly involves statins which are 
basically enzyme inhibitors [21, 20]. It is likely 
that they may inhibit many other essential 
enzymes and thereby causing serious side effects. 
The long term use of statins increases the risk of 
chronic toxic effects. While conventional statin 
drugs directly inhibit the enzyme HMG-CoA 
reductase, which is the rate-limiting enzyme in 
the hepatic metabolic pathway to cholesterol 
synthesis, policosonal limits this same enzyme 
indirectly. Policosanol has proven equivalent to 
or better than several statin drugs like 
simvastatin, pravastatin, lovastatin, probucol etc 
in reducing cholesterol levels and has fewer side 
effects. This dietary supplement also decreases 
several other risk factors for CHD by decreasing 
the oxidation of LDL cholesterol, platelet 
aggregation and endothelial damage.  
Interestingly, these histological changes were in 
accordance of the lipid profile of these animals. 
There was significant decrease in triglyceride & 
cholesterol level accompanied with increase in 
HDL cholesterol (Table B, C). 
All the plant extracts induced an increase in 
serum HDL-C levels when compared to 
hyperlipidemic group as well as to Lovastatin 
group (Table-B). The maximum activity was 
demonstrated by the extract of Oroxylum indicum 
which increased the level of HDL to 34mg/dl 
similar to that of the control group. The extract of 
Vitis vinifera and policosanol showed better 
activity and increased the level of HDL to 32 and 
29mg/dl as similar to standard lovastatin group.  
HDL-C is beneficial for a number of reasons. The 
most important is its ability to drive a process 
called "reverse cholesterol transport”. HDL helps 
to extract excess cholesterol deposited in blood 
vessel walls and deliver it back to the liver for 
elimination through the gastrointestinal tract. In 
general, the higher is the HDL-C, the greater is 
the capacity to remove cholesterol and prevent 
dangerous blockages from developing in blood 
vessels. HDL-C helps to keep blood vessels 
widened thereby promoting better blood flow [22, 
23]. 
The SGOT and SGPT levels of the groups treated 
with plant extract were found to be significantly 
reduced as compared to hyperlipidemic group 
(Table C). The histopathological studies of the 
liver sections illustrate no granular degeneration 
and fatty infiltration due to cholesterol 
administration in the groups treated with the plant 
extracts as depicted in figure 3. The present 
Table C: Effect of plant extracts on parameters like AI & LDL-C: HDL-C ratio and on enzyme activity like SGOT and SGPT. 
               Values are Mean± S.E. of 6 animals. 
               P-values: * < 0.01   
 
Groups AI LDL-C 
HDL-C 
SGPT SGOT 
Control group 1.540±0.01* 0.317±0.03* 35.55±6.48* 174.7±9.968* 
Hyperlipidemic group 7.369±0.28 4.026±0.19 156.1±7.94 250.8±8.728 
Standard group lovastatin 
(10 mg/kg/day) 
3.017±0.12* 1.253±0.10* 43.64±4.75* 204.5±9.848* 
Policosinol 2.258±0.10* 0.19±0.036* 68.02±1.72* 183.9±6.76* 
Vitis vinifera 2.03±0.17* 0.244±0.081* 36.18±3.61* 110.2±4.05* 
Oroxylum indicum 1.36±0.04* 0.084±0.035* 33.42±4.01* 108.4±5.93* 
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findings demonstrate leading antioxidant and 
antihyperlipidemic activity which can be 
explored further with respect to its mechanism of 
action to develop good antihyperlipidemic agents. 
Antioxidant activity is one of the mechanisms for 
lowering the lipid profile but a strong 
antihyperlipidemic activity exhibited by 
Oroxylum indicum indicates that there could be 
other constituents as well as flavonoids and 
polyphenols responsible for its anti 
hyperlipidemic activity. 
 
 
Figure 3 Depicting standard curve of ellagic acid 
isolated from Oroxylum indicum extract 
 
In conclusion, the present study reveals that these 
plant extracts have very potential antioxidant 
activity and antihyperlipidemic activity due to the 
presence of flavonoids and polyphenols which 
could be one of the possible reasons in prevention 
of CHD and myocardial infarction. 
Thus, based on the above scientific observations, 
it could be finally suggested that extracts could 
be targeted as a novel poly-herbal formulation 
with multi-targeted action as it collectively 
inhibits the process of atheroma formation, by 
regulating various steps in atherogenesis. It could 
acts either as (1) antioxidant (2) as 
hypolipidemic, through enhancing the HDL, (3) 
atheroma stabilizer through (a) lesser deposition 
of Ca in the plaque, (b) through maintenance of 
intactness of collagen cap and (c) through less 
proliferation of smooth muscle cells in the 
vascular wall. 
Although, these individual plants are already in 
clinical use as single or in different formulation, 
but multi-centric clinical trial is required to use it 
as food supplement or as add on therapy to 
prevent atherosclerosis and hyper-lipidemia. 
 
Figure 4 Hepatocytes of rats stained with 
hematoxylin and eosin (100 x magnification) – 
(A) control group showing normal architecture; 
(B) Hyperlipidemic group showing granular 
degeneration; (C) Lovastatin group showing mild 
diffuse granular degeneration; (D) Policosanol; 
(E) Vitis vinifera extract; (F) Oroxylum indicum 
extract 
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